Finland· FI-REL-REL25330

Canoderm

A carbamide product containing urea, registered in Finland by ACO Hud Nordic AB. The same ATC class is registered in 5 of our 19 countries.

ATC D02AE01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedCanodermATCD02AE01REGISTER NO.FI-REL-REL25330PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Carbamide is registered in 5 of 19 countries.

Countries holding a registration under ATC D02AE01 (carbamide), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose

Carbamide · ATC D02AE01

5 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Urea
Manufacturer
ACO Hud Nordic AB
Country
Finland (FI)
ATC code
D02AE01
ATC class
Carbamide
Defined daily dose
0.2 g, T
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Carbamide in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carbamide products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Keratosis
  • Czechia · Excipial U Hydrolotio, Excipial U Lipolotio
  • Germany · Balisa, Basodexan
  • Denmark · Canoderm
  • Estonia · Linola
  • Spain · Urea Nm
  • Norway · Canoderm, Curemid
  • Sweden · Canoderm, Curemid
  • Slovenia · Linola
  • Slovakia · Excipial U Hydrolotio, Excipial U Lipolotio

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ee771fb7-b545-4d66-aecb-b9ad0d711d59
GET /v1/drugs/ee771fb7-b545-4d66-aecb-b9ad0d711d59?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "emulsiovoide",
  "route": null,
  "ddd_unit": null,
  "strength": "5 %",
  "atc_label": "karbamidi",
  "ma_number": "21721",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL25330",
  "authorised_at": "2006-07-17"
}

See everything about carbamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.